Dr. Ikwunga Wonodi is the service chief of both the Orchard Unit and Thought Disorders Day Hospital at Sheppard Pratt's Baltimore/Washington Campus. He is the chair of the Sheppard Pratt Physician Practice Association Peer Review Committee. Dr. Wonodi completed his psychiatry residency at University of Maryland/Sheppard Pratt and a fellowship in schizophrenia research at the Maryland Psychiatric Research Center (MPRC). He earned his MD at University of Port Harcourt, Nigeria, and an M.B.A in Healthcare Management from the Johns Hopkins Carey Business School. He is board certified in general psychiatry.
In addition to his work at Sheppard Pratt, Dr. Wonodi is an adjunct associate professor of psychiatry at the University of Maryland School of Medicine and leads collaborative NIH-funded biomarker studies between Sheppard Pratt and MPRC. He is the recipient of awards for clinical education, community service and activities to eliminate mental health disparities. Dr. Wonodi serves on the board of the Black Psychiatrists of America.
College of Health Sciences, University of Port-Harcourt
University of Maryland/Sheppard Pratt
- Distinguished Fellow, American Psychiatric Association
- Treasurer, Black Psychiatrists of America
- Member, Maryland Psychiatric Society
- Member, American Association for Physician Leadership
Patchan K, Vyas G, Hackman AL, Mackowick M, Richardson CM, Love RC, Wonodi I, Sayer MA, Glassman M, Feldman S, Kelly DL. (2018). Clozapine in Reducing Aggression and Violence in Forensic Populations. Psychiatr Q, 89(1):157-168.
Wonodi I, McMahon RP, Krishna N, Mitchell BD, Liu J, Glassman M, Hong LE, Gold JM. (2014). Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia. Schizophr Res, 160(1-3):80-7.
Hong LE, Thaker GK, McMahon RP, Summerfelt A, Rachbeisel J, Fuller RL, Wonodi I, Buchanan RW, Myers C, Heishman SJ, Yang J, Nye A. (2011). Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry, 68(12):1195-206.
Wonodi I, Stine OC, Sathyasaikumar KV, Roberts RC, Mitchell BD, Hong LE, Kajii Y, Thaker GK, Schwarcz R. (2011). Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch Gen Psychiatry, 68(7):665-74.